Leaflet HAEMOCOMPLETTAN P lyophilized and solvent
Indicated for: bleeding; coagulation disorders
Route of administration: injectable
Substance: human fibrinogen (anticoagulant)
ATC: B02BB01 (Blood and blood forming organs | Vitamin k and other hemostatics | Fibrinogen)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Human fibrinogen is an essential blood protein used as a medication to treat or prevent bleeding in patients with fibrinogen deficiency, a rare condition that can be congenital or acquired. Fibrinogen plays a crucial role in blood clotting, helping to form the clots needed to stop bleeding.
Human fibrinogen is administered by intravenous infusion under the strict supervision of medical personnel. The dose and frequency of administration are determined by the doctor, depending on the severity of the deficiency and the patient's needs. Careful monitoring is essential to prevent complications.
Possible side effects include allergic reactions, fever, chills, or an increased risk of blood clots. In rare cases, severe reactions such as anaphylactic shock may occur. If you experience any unusual symptoms, contact your doctor immediately.
Human fibrinogen is vital for patients with bleeding disorders, but its use requires careful medical supervision. Inform your doctor about any other conditions or treatments you are undergoing to reduce the risk of complications.
General data about HAEMOCOMPLETTAN P
- Substance: human fibrinogen
- Date of latest medicines list: 01-07-2013
- Product code: W13381001
- Pharmaceutical form: lyophilized and solvent
- Quantity: 1
- Product type: Generic medicine
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.